Praxis Precision Medicines announced the issuance of incentive allowances in accordance with NASDAQ Listing Rule 5635(C)(4).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.